证券记录 · 已归档季度
ERAS
Erasca, Inc. · Healthcare · Biotechnology
16被追踪持有人
+1Δ持有人
49.01M持有股份
$106.84M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +6.7% ·
股份流向 -4.1% ·
净新建仓位 +6.2%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +13 | 109.93M | $2.01B | +17 | −4 |
| Q1 2026 | 87 | +18 | 99.27M | $1.57B | +25 | −7 |
| Q4 2025 | 69 | +1 | 63.96M | $237.91M | +1 | — |
| Q3 2025 | 16 | +1 | 49.01M | $106.84M | +1 | — |
| Q2 2025 | 12 | -3 | 45.80M | $58.17M | — | −3 |
| Q1 2025 | 12 | 0 | 17.13M | $23.47M | +1 | −1 |
| Q4 2024 | 12 | 0 | 25.73M | $64.58M | +1 | −1 |
| Q3 2024 | 11 | 0 | 18.60M | $50.78M | — | — |
| Q2 2024 | 11 | — | 15.91M | $37.56M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (被动) | 12.81M | +0.9% | $27.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 12.81M | +0.9% | $27.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 12.81M | +0.9% | $27.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 4.85M | +0.3% | $10.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 4.85M | +0.3% | $10.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (被动) | 4.03M | +0.7% | $8.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 2.91M | -23.2% | $6.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 2.52M | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 2.52M | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 2.52M | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 1.02M | +36.7% | $2.21M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 600.58K | -32.2% | $1.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 32 | Wellington Management ✦ | 600.58K | -32.2% | $1.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 33 | Wellington Management ✦ | 600.58K | -32.2% | $1.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 34 | Marshall Wace ✦ | 526.01K | -74.6% | $1.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 419.55K | +11.3% | $914,628 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 419.55K | +11.3% | $914,628 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 347.77K | -18.7% | $758,132 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 341.80K | 新增 | $745,122 | 0.0% | New | 1 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 341.80K | 新增 | $745,122 | 0.0% | New | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 93.58K | +8.2% | $205,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $745,122 | 0.0% |
| Citadel Advisors | $745,122 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 223 持有人, 272.55M 股份, $4.00B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据